| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $166,681,418 ) (Continued on the next page) |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | P01HL116263 | HDL Function in Human Disease | 000 | 10 | NIH | 1/22/2025 | $2,303,452 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23MH134136 | The Impact of Adversity on Neurobiological and Psychosocial Dimensions of the Stress Response System | 000 | 2 | NIH | 3/28/2025 | $185,544 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | T35DC008763 | Developing Research Careers in the Hearing Sciences II | 002 | 18 | NIH | 4/10/2025 | $44,515 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U54AG089326 | Vanderbilt-coordinated human Virome Collaborative Center (V2C2) | 000 | 1 | NIH | 1/22/2025 | $3,984,525 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08AI185260 | A Translational Bioinformatics Approach for Phenotyping and Genetic Risk of Severe Cutaneous Adverse Drug Reactions | 000 | 1 | NIH | 1/15/2025 | $186,332 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL171577 | The Road to Destination Therapy: Developing a Durable Ambulatory Mechanical Cardiopulmonary Support for Pulmonary Hypertension | 000 | 2 | NIH | 1/18/2025 | $671,339 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23DK135414 | Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV | 000 | 3 | NIH | 1/17/2025 | $185,436 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23GM150110 | Improving Prognostication for Traumatic Brain Injury | 000 | 3 | NIH | 4/8/2025 | $173,315 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01NS123281 | Mechanisms of cerebral infarcts and brain oxygen utilization in anemia | 000 | 4 | NIH | 4/30/2025 | $431,490 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R00HL153939 | Genomic Regulation and Translational Potential of a Novel Smooth Muscle Cell-Derived Cell Type in Atherosclerosis | 000 | 4 | NIH | 1/6/2025 | $249,000 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG084550 | Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias | 001 | 1 | NIH | 4/7/2025 | $802,941 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG084550 | Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias | 000 | 1 | NIH | 12/26/2024 | $874,857 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01NS141191 | Cerebrospinal fluid dynamics in Huntington's disease | 000 | 1 | NIH | 12/24/2024 | $621,073 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL160863 | Integrating KCNH2 Variant-Specific Features and Heterozygote Phenotypes to Estimate Long QT Penetrance | 000 | 4 | NIH | 12/31/2024 | $519,502 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK141801 | Liver and kidney responses to bilirubin as a nuclear receptor hormone | 000 | 1 | NIH | 12/30/2024 | $380,625 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08HG014001 | A high-throughput, multimodal strategy to improve variant classification | 000 | 1 | NIH | 1/3/2025 | $172,584 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL167969 | Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials | 000 | 2 | NIH | 12/30/2024 | $664,507 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA289528 | Molecular Mediators of Cell-free DNA biogenesis | 000 | 1 | NIH | 12/16/2024 | $670,147 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01HL156620 | Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease | 001 | 5 | NIH | 3/25/2025 | $757,751 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08NS140767 | Neurophysiology of Reward Signaling in Parkinson's Disease | 000 | 1 | NIH | 12/16/2024 | $176,079 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01MD016838 | Mechanisms of transition from acute to chronic pain in Non-Hispanic Black and White injury patients | 001 | 4 | NIH | 4/30/2025 | $703,726 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK131104 | Obesogenic diet-induced intestinal epithelium repair responses link dysbiosis and cardiovascular disease | 000 | 4 | NIH | 12/17/2024 | $441,231 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R37AI131771 | Statistical methods and designs for correlated outcome and covariate errors in studies of HIV/AIDS | 001 | 8 | NIH | 2/18/2025 | $822,881 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI093234 | Statistical Methods for Ordinal Variables in HIV/AIDS Studies | 000 | 11 | NIH | 12/4/2024 | $600,434 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K99LM014429 | Development and implementation of statistical machine learning methods to shorten rare disease odysseys | 000 | 2 | NIH | 12/9/2024 | $90,612 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL161095 | Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension | 000 | 4 | NIH | 12/5/2024 | $604,522 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI148452 | Vanderbilt Vaccine and Treatment Evaluation Unit | 000 | 6 | NIH | 12/5/2024 | $379,651 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI148452 | Vanderbilt Vaccine and Treatment Evaluation Unit | 000 | 6 | NIH | 12/5/2024 | $621,717 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI093234 | Statistical Methods for Ordinal Variables in HIV/AIDS Studies | 002 | 11 | NIH | 5/6/2025 | $984 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DC020194 | Binaural cue sensitivity in children and adults with combined electric and acoustic stimulation | 000 | 3 | NIH | 11/27/2024 | $596,727 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK131070 | The Origins of Human Anti-Insulin B Lymphocytes in Type 1 Diabetes | 000 | 4 | NIH | 11/25/2024 | $424,564 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI155668 | Comprehensive antigenic mapping of the human anti-peanut IgE antibody response | 000 | 5 | NIH | 11/26/2024 | $747,580 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HG012262 | Rational Integration of Polygenic Risk Scores (RIPS) | 001 | 4 | NIH | 4/28/2025 | $87,881 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HG012262 | Rational Integration of Polygenic Risk Scores (RIPS) | 000 | 4 | NIH | 3/14/2025 | $790,943 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 2 | NIH | 11/22/2024 | $18,104 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 2 | NIH | 11/22/2024 | $150,000 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 2 | NIH | 11/22/2024 | $80,000 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23HD104183 | Biopsychosocial predictors of opioid use for pediatric postsurgical pain | 000 | 5 | NIH | 4/15/2025 | $133,273 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI180038 | Human M Cells Require Coronin 1a | 000 | 2 | NIH | 10/31/2024 | $685,191 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R35GM155339 | From genetic variants to mechanisms: understanding drivers of inflammation | 000 | 2 | NIH | 4/29/2025 | $437,500 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NUR3DD000107 | Tennessee ADDM: Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 00 | 3 | CDC | 12/16/2024 | $725,000 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL158918 | Roles of fibrin(ogen) in conformational activation of hemostatic proteinase precursors | 001 | 4 | NIH | 4/14/2025 | $429,740 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA279249 | Secondary Molecular Imaging (SMI) for head and neck cancer | 000 | 2 | NIH | 2/19/2025 | $343,509 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL173598 | Novel functions of plasminogen and its diverse cargo in blood | 000 | 2 | NIH | 4/22/2025 | $350,000 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL164820 | Non-selective Large Conductance Ion Channels In Triggered Arrhythmia | 000 | 2 | NIH | 3/25/2025 | $491,719 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK133512 | Hepatic stellate cells in liver homeostasis and regeneration | 000 | 2 | NIH | 11/18/2024 | $612,559 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K24HL165163 | Mentoring in cholinergic regulation of vascular oxidation | 000 | 3 | NIH | 4/2/2025 | $115,983 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R35GM150465 | High-throughput discovery of disease-associated ion channel variants | 000 | 3 | NIH | 4/29/2025 | $437,500 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 007 | 1 | NIH | 4/17/2025 | -$19,000,000 |
|
